Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Revenue (Gross) (2021 - 2025)

Abeona Therapeutics (ABEO) has 5 years of Revenue (Gross) data on record, last reported at $1.7 million in Q3 2025.

  • For Q3 2025, Revenue (Gross) rose 40.62% year-over-year to $1.7 million; the TTM value through Sep 2025 reached $5.0 million, up 26.88%, while the annual FY2024 figure was $4.2 million, 100.57% up from the prior year.
  • Revenue (Gross) reached $1.7 million in Q3 2025 per ABEO's latest filing, up from $1.0 million in the prior quarter.
  • Across five years, Revenue (Gross) topped out at $1.7 million in Q3 2025 and bottomed at $7000.0 in Q3 2021.
  • Average Revenue (Gross) over 5 years is $675625.0, with a median of $668000.0 recorded in 2023.
  • Peak YoY movement for Revenue (Gross): skyrocketed 5100.0% in 2023, then fell 13.77% in 2025.
  • A 5-year view of Revenue (Gross) shows it stood at $7000.0 in 2021, then soared by 4585.71% to $328000.0 in 2022, then surged by 126.52% to $743000.0 in 2023, then surged by 37.69% to $1.0 million in 2024, then surged by 63.44% to $1.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue (Gross) were $1.7 million in Q3 2025, $1.0 million in Q2 2025, and $1.3 million in Q1 2025.